Defibrillators Market Size, Share, Growth – By Product, By End Use – Global Forecast, 2025 to 2034

Defibrillators Market Size

The global defibrillators market size was valued at USD 13.6 billion in 2024 and is expected to exhibit growth at a CAGR of 5.4% from 2025 to 2034. The high market growth can be attributed to the rising prevalence of cardiovascular diseases, increasing awareness about life-saving medical devices, and the growing aging population.
 

The rise in the prevalence of cardiac arrhythmias and sudden cardiac arrest (SCA) globally has become a significant driver for the defibrillator market. With heart disease as a leading cause of mortality, particularly in aging populations, defibrillators are in increasing demand for their life-saving potential. These devices play an essential role in delivering rapid intervention during cardiac emergencies and stabilizing patients by restoring heart rhythms. Hospitals, emergency responders, and even public locations are recognizing the necessity of having defibrillators readily available to prevent fatalities. The focus on improving survival rates in cardiac cases is making defibrillators essential in healthcare settings globally.
 

Additionally, technological advancements in defibrillators, such as the development of automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs), further support market growth. These innovations make defibrillators more efficient and user-friendly, driving adoption in both public and clinical spaces. Government initiatives mandating AED installations in public locations—airports, schools, and sports arenas—are also key to market expansion, aiming to enhance public safety. Through these programs, many countries are increasing defibrillator access, improving emergency response readiness, and enhancing public health safety.  
 

A defibrillator is a medical device designed to deliver a dose of electric current to the heart. This electric shock, known as defibrillation, helps restore a normal heartbeat by stopping or interrupting irregular heart rhythms. Defibrillators are commonly used in cases of sudden cardiac arrest to prevent death and ensure rapid response in emergency situations.
 

Defibrillators Market Trends

Several trends are currently shaping the defibrillator market. The adoption of wearable defibrillators, which continuously monitor patients at risk of sudden cardiac arrest and deliver immediate treatment, is growing significantly. These wearable medical devices offer patients greater mobility and a sense of security, especially for those waiting for implantable defibrillator surgeries.
 

• Additionally, the integration of smart technology in defibrillators, such as Bluetooth-enabled data sharing and cloud connectivity, is driving innovation. Such features allow healthcare providers to remotely monitor device performance and patients cardiac health in real time, enhancing patient care and adherence to follow-ups. Also, increased emphasis on public access defibrillation (PAD) programs in schools, airports, and public transport stations is another key trend, aimed at providing timely response in cases of out-of-hospital cardiac arrests.
   
• In regions with aging populations, particularly in Europe and North America, there is a growing awareness about the benefits of home-use defibrillators, which is contributing to increased demand. Together, these trends are expected to drive innovation and accessibility in the defibrillator market.
   

Defibrillators Market Analysis

Based on product, the market is segmented as implantable cardioverter defibrillator (ICD) and external cardioverter defibrillator. The implantable cardioverter defibrillator (ICD) segment is expected to drive business growth and expand at a CAGR of 5.2%, reaching over USD 16.7 billion by 2034.
 

• ICDs hold a major share of the defibrillator market due to their high effectiveness in preventing sudden cardiac death among high-risk patients. ICDs continuously monitor a patient’s heart rhythm and automatically deliver an electric shock to correct life-threatening arrhythmias. This reliability in early detection and immediate response has made ICDs a preferred choice among cardiologists, particularly for patients with severe heart conditions or a history of cardiac arrest. Their long-term implantation and compatibility with other cardiac monitoring systems also make ICDs a cost-effective option over time, reducing the need for frequent medical interventions.
   
• In addition, the growing prevalence of cardiovascular diseases and the increasing number of patients opting for ICD implants are contributing to the segments dominance. With advancements in battery technology and device miniaturization, ICDs have become more comfortable and convenient for patients. Furthermore, their compatibility with remote monitoring systems allows healthcare providers to closely track patients heart conditions and receive alerts in case of irregularities.
   

Based on end use, the defibrillators market is classified into hospitals, ambulatory surgical centers, and other end users. The hospital segment dominated the market with a revenue share of 67.8% in 2024.
 

• As critical care centers, hospitals are equipped with advanced defibrillator devices, including both ICDs and AEDs, to address life-threatening cardiac conditions. The availability of skilled healthcare professionals who can effectively operate defibrillators in emergencies further positions hospitals as primary end-users in this market.
   
• Additionally, hospitals frequently serve patients with complex heart conditions who require continuous cardiac arrythmia monitoring, increasing the need for advanced defibrillation solutions to manage and prevent cardiac arrest events. Furthermore, initiatives to incorporate digital health technologies in hospitals enable remote monitoring and timely alerts for high-risk patients, making hospitals a central distribution point for defibrillators and reinforcing their significant market share.   
   

The U.S. defibrillators market accounted for USD 4.6 billion market revenue in 2024 and is anticipated to grow at a CAGR of 4.5% between 2025 to 2034 period.
 

• The U.S. defibrillator market is growing due to high healthcare expenditure, strong infrastructure, and supportive government policies. Programs promoting public access to defibrillators in public places and schools have contributed to the widespread adoption of AEDs. For example, the U.S. requires AEDs in locations like airports, offices, and educational institutions, which has normalized public access to defibrillation and improved cardiac response rates.
   
• The increasing prevalence of heart disease and technological innovation have also driven adoption. The aging population in the U.S. further fuels the demand for ICDs and wearable defibrillators to support at-risk patients. These factors make the U.S. a key market, with substantial investment in advanced defibrillator technology and supportive reimbursement policies.
   

The UK defibrillators market is projected to grow remarkably in the coming years.

• In the UK, defibrillator adoption is rising due to government support and public health initiatives. The British Heart Foundation promotes the installation of AEDs in community spaces, aiming to improve survival rates for out-of-hospital cardiac arrests. Increased public awareness campaigns have also encouraged adoption in schools and sports centers.
   
• Moreover, the UK's National Health Service (NHS) has integrated defibrillator use in emergency medical services, improving cardiac response times. With a steadily aging population, the UK market shows a growing demand for both AEDs and ICDs, with the latter preferred for patients with high cardiovascular risks.
   

China holds a dominant position in the Asia Pacific defibrillators market.
 

• In China, the defibrillator market is expanding due to increased government focus on healthcare accessibility and infrastructure. The Chinese government has implemented public health programs to equip high-traffic areas with AEDs, recognizing the role of early defibrillation in improving survival rates. Major cities like Beijing and Shanghai have launched initiatives to install AEDs in public places, which is encouraging adoption.
   
• Growing awareness of heart disease prevention has also spurred demand for ICDs in clinical settings. Rising healthcare investments and modernization of emergency services contribute to the increased adoption of defibrillators, with China emerging as a promising market for AED and ICD manufacturers looking to expand in Asia.
   

Defibrillators Market Share

Several key players in the market are making strides in product innovation and strategic partnerships to maintain market leadership. Companies are investing heavily in R&D to develop advanced defibrillators with enhanced features such as Bluetooth connectivity, remote patient monitoring, and enhanced battery life. Additionally, partnerships with healthcare providers are being forged to improve product accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient defibrillators.
 

Defibrillators Market Companies

Prominent players operating in the defibrillators industry include:

• Abbott
• Amiitalia
• Asahi KASEI
• BIOTRONIK
• Boston Scientific
• BPL Medical Technologies
• CU MEDICAL
• MEDITECH
• Medtronic
• MicroPort
• mindray
• NIHON KOHDEN
• Philips
• SCHILLER
• Stryker
   

Defibrillators Industry News:

• In October 2023, Medtronic received FDA approval for its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, a groundbreaking device designed to treat abnormal heart rhythms and prevent sudden cardiac arrest. Unlike traditional ICDs, the EV ICD places the lead outside the heart and veins, reducing potential complications associated with transvenous leads. This new device combines the benefits of an implantable defibrillator with minimized surgical invasiveness, offering a novel option for patients needing defibrillation therapy.  
   
• In May 2024, Defibtech announced an expansion of its Lifeline VIEW and ECG defibrillator product lines within the U.S. This expansion aims to make these advanced, user-friendly defibrillators more widely available to support both public and professional use. The Lifeline VIEW defibrillators feature easy-to-follow video instructions, enhancing accessibility during emergency situations.   
   

The defibrillators market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Implantable cardioverter defibrillator (ICD)
  • Transvenous implantable cardioverter defibrillator
    • Dual-chamber ICDs
    • Single-chamber ICDs
  • Subcutaneous implantable cardioverter defibrillator
• External cardioverter defibrillator
  • Manual ED
  • Automated ED
    • Semi-automated external defibrillator
    • Fully automated external defibrillator
  • Wearable cardioverter defibrillator

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE